Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 13/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 12/20 | 0.53 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6874715 | 1.00 | MCHR1 (0.53) | MCHR1ADRA2AHTR1AADRA1AHRH1 | |
| SCHEMBL6877666 | 0.90 | MCHR1 (0.53) | MCHR1ADRA2ARAB9AMAPT | |
| SCHEMBL6877671 | 0.90 | MCHR1 (0.53) | MCHR1ADRA2ARAB9AMAPT | |
| SCHEMBL6458632 | 0.88 | MCHR1 (0.52) | MCHR1ADRA2ARAB9AMAPT | |
| SCHEMBL6458637 | 0.88 | MCHR1 (0.52) | MCHR1ADRA2ARAB9AMAPT | |
| SCHEMBL6875760 | 0.88 | MCHR1 (0.57) | MCHR1ADRA2AHTR1AADRA1AHRH1 | |
| SCHEMBL6875767 | 0.88 | MCHR1 (0.57) | MCHR1ADRA2AHTR1AADRA1AHRH1 | |
| SCHEMBL6458281 | 0.87 | MCHR1 (0.59) | MCHR1ADRA2AHTR1AADRA1AHRH1 | |
| SCHEMBL6458289 | 0.87 | MCHR1 (0.59) | MCHR1ADRA2AHTR1AADRA1AHRH1 | |
| SCHEMBL6455649 | 0.85 | MCHR1 (0.72) | MCHR1ADRA2AHTR1AADRA1AHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1798736-A | Novel quinoline, tetrahydroquinazoline and pyrimidine derivatives and methods of treatment related to their use | ARENA PHARM INC (JP) | 2006-07-05 | — | — | CN | disclosed |
| EP-1464335-A2 | Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist | Taisho Pharmaceutical Co. Ltd. (JP) | 2004-10-06 | — | — | EP | disclosed |